Preterm Birth Diagnostic Test Kits Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Preterm Birth Diagnostic Test Kits Market size is expected to grow significantly from 2019 to 2025.
 

Preterm birth diagnostic test kits industry is anticipated to grow significantly during the forecast timeline. The business growth is attributable to increasing focus on cost-effective diagnosis for detecting preterm birth. Moreover, manufacturers and several organizations emphasize on spreading awareness regarding preterm birth through various campaigns are factors that will boost preterm birth diagnostic test kits industry growth over the coming years. Additionally, preterm birth has been associated to growing number of perinatal mortality and morbidity relating to newborns born deprived of congenital irregularities. The main long-term significance of prematurity is neurodevelopmental disability. Aforementioned, risk factors encourage early diagnosis that is expected to foster business growth.
 

Surging number of diagnostic tests for preterm birth coupled with increasing demand for preterm diagnosis is anticipated to favor preterm birth diagnostic test kits market growth during the forecast timeline. Furthermore, changes in sedentary lifestyle and lack of physical activities are factors that upsurge premature births and it also accelerated complications associated with same. Above-mentioned aspects boost preterm birth diagnostic test kits industry growth. However, high cost associated with preterm birth and its long-term cost are factors that might hamper business growth to some extent.
 

fFN Test Kits segment is expected to grow substantially over the analysis timeframe. The growth is mainly attributable to associated advantages of fFN test. Additionally, fFN are projected for usage of other clinical data to evaluate the risk of preterm birth in females with indications of preterm labor that have unbroken amniotic membranes. The obtained results can assist clinicians in decision making of hospital admittance whether required for improvement in neonatal outcomes and treatment to postpone birth, thus, can foster segmental growth.
 

Hospitals segment is projected to witness robust CAGR during the forecast period due to growing awareness concerning preterm birth and early diagnosis of preterm birth. Additionally, increasing cases of preterm birth coupled with surging demand for preterm birth test kits and cost-effective diagnosis should further propel segmental growth over the coming years.
 

North America preterm birth diagnostic test kits market will grow significantly on an account of factors such as increasing preterm births coupled with well-established healthcare infrastructure. Furthermore, surging adoption of diagnostic tests for preterm birth in the region is anticipated to boost business growth.
 

Some of the prominent industry players operational in preterm birth diagnostic test kits market share includes Abbott, Clinical Innovations, Creative Diagnostics, Hologic, IQ Products, Medixbiochemica, Qiagen, and Sera Prognostics. Major industry players adopt various strategies in order to obtain more market share. These companies focus on strategic initiatives such as collaborations, mergers, new product launches and acquisitions. For instance, in December 2018, Sera Prognostics, Inc., received clinical laboratory certificate for Sera to perform PreTRM testing for expecting women in the state of New York. Additionally, with the help of approval Sera commercializes PreTRM test in New York.
 

Preterm Birth Diagnostic Test Kits Market By Product, 2014-2025 (USD Million)

• fFN Test Kits
• PAMG-1 Test Kits
• IGFBP 1 Test Kits
• Others

Preterm Birth Diagnostic Test Kits Market By End-use, 2014-2025 (USD Million)

• Hospitals
• Clinics
• Diagnostic Laboratories
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
• Middle East and Africa
  • Saudi Arabia
  • South Africa

Company Profiles:

• Abbott
• Biosynex
• Clinical Innovations, LLC
• CooperSurgical Inc.
• Creative Diagnostics
• Hologic, Inc.
• IQ Products
• Medixbiochemica
• Qiagen
• Sera Prognostics

What Information does this report contain?